Latest Alpha Tau Medical News & Updates

See the latest news and media coverage for Alpha Tau. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alpha Tau Medical (Alpha Tau)

Clinical-stage oncology company developing intratumoral alpha-emitting radiotherapeutics

alphatau.com
Headquarters
Jerusalem , Israel
Founded year
2016
Company type
Private company
Number of employees
120–200

Last updated

Latest news about Alpha Tau Medical (Alpha Tau)

In short: Alpha Tau reported positive interim REGAIN results, with all six evaluable patients responding

Company announcements

Alpha Tau

Alpha Tau reports Q3 2026 financial results

It posts a $98.9 million nine-month net loss and holds $99.8 million in cash, while reporting REGAIN glioblastoma responses and completing IMPACT enrollment.

Alpha Tau

Alpha Tau reports Q2 2026 results and corporate update

The company reported a $68.8 million net loss, $104.8 million cash balance, and Tolmar collaboration for prostate cancer, with multiple clinical milestones.

Unlock all announcements with a

Media coverage

BioSpace

Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update - BioSpace

JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation...

Unlock all articles with a

Never miss news about Alpha Tau

Track Alpha Tau and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.